Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × fluarix × 90 days × Clear all

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 283 pembrolizumab 251 Magnetic Resonance Spectroscopy 228 Carboplatin 156 Biopsy 153 Cyclophosphamide 138 Cisplatin 132 Paclitaxel 110 Gemcitabine 103 Radiotherapy 101 Bevacizumab 99 venetoclax 90 Nivolumab 89 fludarabine 86 Dexamethasone 86 Oxaliplatin 67 Fluorouracil 66 Docetaxel 65 Rituximab 64 Capecitabine 64 Drug Therapy 62 Pemetrexed 61 Standard of Care 60 atezolizumab 56 Injections 56 durvalumab 55 Radiosurgery 55 X-Rays 53 Radiation 53 Leucovorin 52

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡